Actively Recruiting
REACT - Resistance Exercise After Cancer Treatment
Led by Inland Norway University of Applied Sciences · Updated on 2025-09-08
120
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
Sponsors
I
Inland Norway University of Applied Sciences
Lead Sponsor
S
Sykehuset Innlandet HF
Collaborating Sponsor
AI-Summary
What this Trial Is About
Resistance exercise has been shown to improve several important health variables after cancer and cancer related treatment, but unfortunately the adherence to resistance exercise is low. Typical reported exercise barriers are inconvenient location (e.g. long distance from home), exercise at an unfavorable time of the day, inadequate access to cancer-specific exercise and insufficient recommendations from healthcare providers. Thus, there is need for more research on resistance exercise with an alternative approach in cancer rehabilitation, that potentially can target a broad range of patients, despite their domicile. In Norway, the foundation "Active against cancer" has established exercise locations tareting cancer patients in several hospitals, and today they also offer digital home-based exercise sessions. Therefore, the overall research objectives are to compare the efficacy of 12 weeks digital, home-based resistance exercise program on cancer patients after treatment on functional, mental, and metabolic health, compared to the same program conducted in a studio under guidance of an instructor. The primary aim is to compare the effect on exercise adherence between digital home-based exercise program and on-site guided program on cancer patients after treatment. Secondary aims are to compare the two groups on several functional health outcomes, mental health outcomes and metabolic health markers.
CONDITIONS
Official Title
REACT - Resistance Exercise After Cancer Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older and able to give informed consent
- Previously diagnosed with any form of cancer and completed systemic chemotherapy, immunotherapy, targeted therapies, or local radiotherapy
- Completed active cancer treatment within the last 12 months or currently undergoing oral home-based treatment for disease stabilization or relapse prevention
- Life expectancy greater than 12 months
- Have digital access at home (e.g., computer, tablet) and an email address to log on to the exercise platform
- Able to understand Norwegian language
You will not qualify if you...
- Serious heart, lung, or other organ diseases preventing exercise as per protocol
- Cancer-related conditions prohibiting exercise such as major surgery, fractures, or pain
- Currently undergoing active cancer treatment with high risk of bone marrow suppression leading to infections, bleeding, or severely reduced physical capacity
- Life expectancy less than 12 months
- Reduced mental capacity preventing informed consent or following the program
- Living more than 20 km away from the exercise locations (Gjøvik or Lillehammer) if considered for randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Inland Norway University of Applied Sciences
Lillehammer, Norway
Actively Recruiting
Research Team
A
Anne Mette Rustaden, PhD
CONTACT
S
Stian Ellefsen, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here